HLA-C*06:02-independent, gender-related association of PSORS1C3 and PSORS1C1/CDSN single-nucleotide polymorphisms with risk and severity of psoriasis

[1]  F. Capon.  The Genetic Basis of Psoriasis , 2017, International journal of molecular sciences.

[2]  A. Szczerkowska-Dobosz,et al.  The association of ERAP1 and ERAP2 single nucleotide polymorphisms and their haplotypes with psoriasis vulgaris is dependent on the presence or absence of the HLA-C*06:02 allele and age at disease onset. , 2017, Human immunology.

[3]  J. Rossjohn,et al.  The molecular basis for peptide repertoire selection in the human leukocyte antigen (HLA) C*06:02 molecule , 2017, The Journal of Biological Chemistry.

[4]  M. Eriksson,et al.  Severity of Psoriasis Differs Between Men and Women: A Study of the Clinical Outcome Measure Psoriasis Area and Severity Index (PASI) in 5438 Swedish Register Patients , 2017, American Journal of Clinical Dermatology.

[5]  F. Slack,et al.  Targeting noncoding RNAs in disease , 2017, The Journal of clinical investigation.

[6]  H. Adami,et al.  Nasopharyngeal carcinoma risk prediction via salivary detection of host and Epstein-Barr virus genetic variants , 2016, Oncotarget.

[7]  J. Ocampo-Candiani,et al.  Candidate gene polymorphisms and risk of psoriasis: A pilot study , 2016, Experimental and therapeutic medicine.

[8]  S. Krebs,et al.  Melanocyte antigen triggers autoimmunity in human psoriasis , 2015, The Journal of experimental medicine.

[9]  A. Bowcock,et al.  The immunogenetics of Psoriasis: A comprehensive review. , 2015, Journal of autoimmunity.

[10]  R. Queiró,et al.  Age at disease onset: a key factor for understanding psoriatic disease. , 2014, Rheumatology.

[11]  M. Simpson,et al.  An In-Depth Characterization of the Major Psoriasis Susceptibility Locus Identifies Candidate Susceptibility Alleles within an HLA-C Enhancer Element , 2013, PloS one.

[12]  C. López-Larrea,et al.  Clinical Differences between Men and Women with Psoriatic Arthritis: Relevance of the Analysis of Genes and Polymorphisms in the Major Histocompatibility Complex Region and of the Age at Onset of Psoriasis , 2013, Clinical & developmental immunology.

[13]  J. Kere,et al.  Centrosomal Localization of the Psoriasis Candidate Gene Product, CCHCR1, Supports a Role in Cytoskeletal Organization , 2012, PloS one.

[14]  I. Kockum,et al.  Genetic Association with ERAP1 in Psoriasis Is Confined to Disease Onset after Puberty and Not Dependent on HLA-C*06 , 2012, The Journal of investigative dermatology.

[15]  A. Bowcock,et al.  Protective Effect of Human Endogenous Retrovirus K dUTPase Variants on Psoriasis Susceptibility , 2012, The Journal of investigative dermatology.

[16]  M. Simon,et al.  Corneodesmosomes and corneodesmosin: from the stratum corneum cohesion to the pathophysiology of genodermatoses. , 2011, European journal of dermatology : EJD.

[17]  Matti Pirinen,et al.  A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1 , 2010, Nature Genetics.

[18]  James T. Elder,et al.  Multiple Loci within the Major Histocompatibility Complex Confer Risk of Psoriasis , 2009, PLoS genetics.

[19]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[20]  S. Tsai,et al.  Psoriasis vulgaris in Chinese individuals is associated with PSORS1C3 and CDSN genes , 2006, The British journal of dermatology.

[21]  Stefan Jenisch,et al.  Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene. , 2006, American journal of human genetics.

[22]  T. Wienker,et al.  Male restricted genetic association of variant R620W in PTPN22 with psoriatic arthritis. , 2006, The Journal of investigative dermatology.

[23]  J. Marchand,et al.  Perifollicular and perivascular mouse skin mast cells express corticotropin-releasing hormone receptor. , 2006, The Journal of investigative dermatology.

[24]  H. Yasuda,et al.  Prognostic Factor Analysis for Plaque Psoriasis , 2005, Dermatology.

[25]  S. Fisher,et al.  Corneodesmosin (CDSN) gene association with psoriasis vulgaris in Caucasian but not in Japanese populations , 2005, Clincal and Experimental Dermatology.

[26]  Y. Chang,et al.  A study of PSORS1C1 gene polymorphisms in Chinese patients with psoriasis , 2005, The British journal of dermatology.

[27]  Jochen Schmitt,et al.  The Psoriasis Area and Severity Index Is the Adequate Criterion to Define Severity in Chronic Plaque-Type Psoriasis , 2005, Dermatology.

[28]  Richard C Trembath,et al.  A synonymous SNP of the corneodesmosin gene leads to increased mRNA stability and demonstrates association with psoriasis across diverse ethnic groups. , 2004, Human molecular genetics.

[29]  R. Trembath,et al.  Haplotype analysis of distantly related populations implicates corneodesmosin in psoriasis susceptibility , 2003, Journal of medical genetics.

[30]  M. Mańczak,et al.  Strong association of HLA-Cw6 allele with juvenile psoriasis in Polish patients. , 2003, Immunology letters.

[31]  R. Trembath,et al.  Family-based analysis using a dense single-nucleotide polymorphism-based map defines genetic variation at PSORS1, the major psoriasis-susceptibility locus. , 2002, American journal of human genetics.

[32]  R. Trembath,et al.  Searching for the major histocompatibility complex psoriasis susceptibility gene. , 2002, The Journal of investigative dermatology.

[33]  J. Gulcher,et al.  HLA-Cw6-positive and HLA-Cw6-negative patients with Psoriasis vulgaris have distinct clinical features. , 2002, The Journal of investigative dermatology.

[34]  R. Vaughan,et al.  Corneodesmosin Expression in Psoriasis Vulgaris Differs from Normal Skin and Other Inflammatory Skin Disorders , 2001, Laboratory Investigation.

[35]  James T. Elder,et al.  Localization of psoriasis-susceptibility locus PSORS1 to a 60-kb interval telomeric to HLA-C. , 2000, American journal of human genetics.

[36]  James T. Elder,et al.  Corneodesmosin gene polymorphism demonstrates strong linkage disequilibrium with HLA and association with psoriasis vulgaris. , 1999, Tissue antigens.

[37]  N. Camp,et al.  Novel genetic association between the corneodesmosin (MHC S) gene and susceptibility to psoriasis. , 1999, Human molecular genetics.

[38]  J. Browne,et al.  Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis. , 1997, Human molecular genetics.

[39]  E. Christophers,et al.  Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. , 1985, Journal of the American Academy of Dermatology.

[40]  Richard C Trembath,et al.  The major psoriasis susceptibility locus PSORS1 is not a risk factor for late-onset psoriasis. , 2005, The Journal of investigative dermatology.

[41]  K. P. O'Brien,et al.  HLA-Cw*0602 associates more strongly to psoriasis in the Swedish population than variants of the novel 6p21.3 gene PSORS1C3. , 2005, Acta dermato-venereologica.

[42]  C. Carcassi,et al.  Mapping of the major psoriasis-susceptibility locus (PSORS1) in a 70-Kb interval around the corneodesmosin gene (CDSN). , 2005, American journal of human genetics.